Showing results (1201-1210 of 1,242) with videos related to
Sort By:
Pageof 125
Nature Medicine|March 14, 2007
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic diseaseJean-Pyo Lee, Mylvaganam Jeyakumar, Rodolfo Gonzalez, et al.ACS Nano|April 15, 2026
Event-Driven Neuromorphic Gaze Decoding via e-Skin ElectrooculographySiwoo Jeong, Hyun Woo Ko, Ji-Hoon Kang, et al.Journal of Nanobiotechnology|May 12, 2026
A novel mRNA-based multi-cytokine strategy to reprogram the peritoneal tumor microenvironment in ovarian cancerYu-Sun Lee, Jisun Lee, Yeeun Lee, et al.Surgical Endoscopy|April 7, 2021
Long-term outcomes of endoscopic resection followed by additional surgery after non-curative resection in undifferentiated-type early gastric cancer: a nationwide multi-center studyJie-Hyun Kim, Young-Il Kim, Ji Yong Ahn, et al.Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.BMC Gastroenterology|December 19, 2023
Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority studyHyun Lim, Jong Kyu Park, Hyunsoo Chung, et al.Journal of Neurogastroenterology and Motility|October 10, 2023
Real-world Prescription Patterns and Patient Satisfaction Regarding Maintenance Therapy of Gastroesophageal Reflux Disease: An Observational, Cross-sectional, Multicenter StudyCheal Wung Huh, Nak Hoon Son, Young Hoon Youn, et al.Journal of Neurogastroenterology and Motility|January 28, 2014
Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With OctyloniumKang Nyeong Lee, Oh Young Lee, Myung-Gyu Choi, et al.Gut and Liver|September 12, 2019
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for <i>Helicobacter pylori</i> Infection: A Nationwide Randomized Trial in KoreaBeom Jin Kim, Hyuk Lee, Yong Chan Lee, et al.Nature|January 18, 2023
Non-epitaxial single-crystal 2D material growth by geometric confinementKi Seok Kim, Doyoon Lee, Celesta S Chang, et al.Pageof 125